All In Biotech

Drug Trial Radar · NCT06344091

A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients

A Real World Study on Local Infiltration of Bupivacaine Liposome Injection for Acute Postoperative Pain After Pediatric Orthopedic Surgery

Last checked: Nov 20, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

232

Planned (sponsor's estimate)

Start

May 21, 2024

Primary completion

May 2027

Study completion May 2027

Sponsor

Sponsor type
Industry
First posted
Apr 3, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 6 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is being conducted to evaluate the safety and efficacy of bupivacaine liposome injection for local infiltration analgesia in pediatric orthopedic surgery in the real world.

Conditions

  • Local Analgesia Via Infiltration

Interventions

  • Bupivacaine Liposome InjectionDrug

    Bupivacaine Liposome Injection 4 mg/kg (up to a maximum of 266 mg)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The incidence of Treatment Emergent Adverse events (TEAE) in the cardiac and nervous systemTime frame: 0 minute to 14 days after administration

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Guangzhou Women and Children's Medical Center

    Guangzhou, Guangdong, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.